Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US
  • CME
  • CE

Credits Available
Physicians: maximum of 0.5 AMA PRA Category 1 Credits
Registered Nurses: 0.5 Nursing contact hours
Pharmacists: 0.5 contact hours (0.05 CEUs)
Released: October 13, 2022 Expiration: October 12, 2023
Start Activity
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by an educational grant from:
Gilead Sciences, Inc.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
person default
Melinda Tran
person default
Thuan Vu, MD
Jennifer Wild, MS, BSN, RN, OCN

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Implement strategies to counter common barriers that hamper patients’ ability to engage with HBV screening, diagnosis, and treatment services
  • Apply interventions to maximize uptake of HBV care by members of Asian and Pacific Islander communities in the United States

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Melinda Tran
Melinda Tran has no relevant financial relationships to disclose.
Thuan Vu, MD
Thuan Vu, MD, has no relevant financial relationships to disclose.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine
Department of Gastroenterology and Hepatology
Stanford University Medical Center
Palo Alto, California

Mindie Nguyen, MD: research support: Exact Science, Gilead, GSK, Intercept, Laboratory of Advanced Medicine, Lilly; consultant/advisor/speaker: Exact Science, Gilead, GSK, Intercept, Laboratory of Advanced Medicine, Lilly.

Jennifer Wild, MS, BSN, RN, OCN
Jennifer Wild, MS, BSN,RN, OCN has no relevant financial relationships to disclose.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Julie Skowronski, NP
Julie Skowronski, FNP-BC, has no relevant conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who provide care for patients with HBV infection.

Goal

The goal of this activity is to improve learners’ ability to overcome barriers to HBV screening, diagnosis, and treatment services through the insights of patient perspectives.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-256-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 13, 2022, through October 12, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US
  • CME
  • CE

Loading...
Hear patient and faculty insights as they discuss barriers to effective HBV screening, diagnosis, linkage to care, and treatment in Asian communities, as well as practical solutions to mitigate those barriers.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
person default
Melinda Tran
person default
Thuan Vu, MD
Jennifer Wild, MS, BSN, RN, OCN
Physicians: maximum of 0.5 AMA PRA Category 1 Credits
Registered Nurses: 0.5 Nursing contact hours
Pharmacists: 0.5 contact hours (0.05 CEUs)
Released: October 13, 2022 Expiration: October 12, 2023

Related Content

Dr Graham Foster on optimizing management of HBV in older adults, from Clinical Care Options (CCO)

Graham R. Foster, FRCP, PhD Released: January 17, 2023

Expert analysis by Dr Nancy Reau on new viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 8, 2022

Clinical Care Options (CCO) expert analysis by Dr Stefan Zeuzem on new viral hepatitis data from AASLD 2022

Stefan Zeuzem, MD Released: December 7, 2022

Dr Nancy Reau: practice-changing viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 6, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by an educational grant from:
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings